Prenetics' IM8 Brand Secures Global Partnership with NBA Star Giannis Antetokounmpo, Who Takes Equity Stake

summarizeSummary

Prenetics' IM8 brand announced a multi-year global partnership with NBA star Giannis Antetokounmpo, who will become a shareholder by taking equity over cash, significantly boosting IM8's market reach and credibility.

check_boxKey Events

• Global Partnership with Giannis Antetokounmpo

  Prenetics' IM8 brand has entered a multi-year global partnership with NBA Champion and two-time MVP Giannis Antetokounmpo, leveraging his extensive global reach and influence.

• Giannis Becomes IM8 Shareholder

  Giannis Antetokounmpo will become a Global Partner and the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, opting for 100% equity over cash compensation, demonstrating strong belief in the company.

• Strategic Market Expansion and Credibility Boost

  The partnership is expected to expand IM8's addressable market, particularly among the 18-34 demographic, and deepen its cross-sport credibility, adding basketball to its roster of athlete shareholders from football, tennis, and Formula 1.

• Accelerates IM8's Rapid Growth Trajectory

  IM8, which reached $100 million in annualized recurring revenue within 11 months and projects $180 million to $200 million in 2026 revenue, anticipates further acceleration from this high-profile partnership.

auto_awesomeAnalysis

This 6-K filing announces a significant multi-year global partnership between Prenetics' IM8 health and longevity brand and NBA superstar Giannis Antetokounmpo. The partnership is highly impactful as Antetokounmpo, with over 35 million social media followers, is not only endorsing the brand but also becoming a shareholder by taking 100% equity over cash compensation. This signals strong conviction in IM8's future and provides a substantial boost to brand credibility and global market reach, particularly in the 18-34 demographic and new international markets via NBA broadcasts. The company highlights IM8's rapid growth, achieving $100 million in annualized recurring revenue within 11 months and projecting $180 million to $200 million in revenue for 2026, which this partnership is expected to accelerate. This strategic move, coupled with the company's strong liquidity position, positions IM8 for continued expansion and reinforces its unique partner alignment model.